Proton therapy in the management of luminal gastrointestinal cancers: Esophagus, stomach, and anorectum Review


Authors: Kobeissi, J. M.; Simone, C. B. 2nd; Hilal, L.; Wu, A. J.; Lin, H.; Crane, C. H.; Hajj, C.
Review Title: Proton therapy in the management of luminal gastrointestinal cancers: Esophagus, stomach, and anorectum
Abstract: While the role of proton therapy in gastric cancer is marginal, its role in esophageal and anorectal cancers is expanding. In esophageal cancer, protons are superior in sparing the organs at risk, as shown by multiple dosimetric studies. Literature is conflicting regarding clinical signifi-cance, but the preponderance of evidence suggests that protons yield similar or improved oncologic outcomes to photons at a decreased toxicity cost. Similarly, protons have improved sparing of the organs at risk in anorectal cancers, but clinical data is much more limited to date, and toxicity ben-efits have not yet been shown clinically. Large, randomized trials are currently underway for both disease sites. © 2022 by the authors. Submitted for possible open access.
Keywords: toxicity; esophageal cancer; gastric cancer; anorectal cancer; proton beam therapy; pencil beam scanning; luminal gastrointestinal cancers
Journal Title: Cancers
Volume: 14
Issue: 12
ISSN: 2072-6694
Publisher: MDPI  
Date Published: 2022-06-02
Start Page: 2877
Language: English
DOI: 10.3390/cancers14122877
PROVIDER: scopus
PMCID: PMC9221464
PUBMED: 35740544
DOI/URL:
Notes: Review -- Export Date: 1 July 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Abraham Jing-Ching Wu
    400 Wu
  2. Carla Hajj
    164 Hajj
  3. Christopher   Crane
    201 Crane
  4. Charles Brian Simone
    190 Simone